From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
How does aflibercept and FOLFIRI work? Aflibercept is a type of targeted cancer drug. Cancers need a blood ... A low DPD level means you are more likely to have severe side effects from this ...
Nicole Cianciotti had driven only about 4½ miles from UPMC Children’s East when she got the call that her son Braeden’s left ...
On the other hand, the more aggressive prostate cancers account for more cancer-related mortality than any other cancer except lung cancer ... cancer detection but does not decrease mortality.
Nicotine alone does not ... to develop lung cancer than those without the mutation who have smoked. Effect of Germline Mutations on Treatment Even when somatic mutations are present in a tumor, the ...
However, getting too much potassium can also cause side effects, some common and some severe. Some studies suggest that higher intakes of potassium may reduce the risk of diseases like high blood ...
Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...
The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...
Study: Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Image Credit: crystal light/Shutterstock In a recent study published ...
This paper presents the important discovery that lipid metabolic imbalance caused by Snail, an EMT-related transcription factor, contributes to the acquisition of chemoresistance in cancer cells.
AstraZeneca’s Tagrisso can be used alongside chemotherapy as a frontline therapy for EGFR-positive non-small cell lung cancer (NSCLC), according to the FDA, consolidating its position as the ...
rare type of small cell lung cancer that primarily affects younger people who have never ... Sep. 5, 2024 — A cancer study found that certain gut bacteria may influence whether or not a patient ...